Back

New Guidelines and their impact on heart valve therapies

30 August 2025 (15:18 - 15:33)
Organised by: Logo
Congress Presentation Part of: How the new guidelines and innovations impact the daily management of patients with heart valves diseases Valvular Heart Disease Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Ralph Stephan von Bardeleben

University Medical Center of Mainz, Mainz (Germany)

4 More presentations in this session

Presentation thumbnail
Session introduction
Professor B. Assmus (Giessen, DE) Professor D. Capodanno (Catania, IT)
Presentation thumbnail
When innovation and evidence disrupt the TAVI landscape
Professor N. van Mieghem (Genk, BE)
Presentation thumbnail
When durable TEER outcomes are supported by proven technologies
Professor M. Kessler (Ulm, DE)
Presentation thumbnail
Key learnings
Professor B. Assmus (Giessen, DE) Professor D. Capodanno (Catania, IT)

Access the full session

Session thumbnail
How the new guidelines and innovations impact the daily management of patients with heart valves diseases

The Event

Event poster

ESC Congress 2025

30 August 2025 15:18 CET
You may be interested in
thumbnail
Webinar
The evidence behind the current VHD guidelines. ESC 2021 Clinical Practice Guidelines - Webinar Series
15 June 2022
thumbnail
Congress Session
ESC Paul Hugenholtz Lecture in Innovation
25 August 2023
thumbnail
Congress Session
Personalised approach to decompensated heart failure
17 May 2025
thumbnail
Webinar
Structural heart interventions in aortic valvular disease - IC Core Curriculum 2
4 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources